Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Conversation, January 26, 2011 - Adenovirus 

Submission Type: BLA    Submission ID: 125296/0    Office: OVRR
Product: Adenovirus Vaccine Live Oral Type 4 and Type 7
Applicant: Teva Women's Health, Inc.
Telecon Date/Time: 26-Jan-2011 04:08 PM        Initiated by FDA? Yes
Communication Category:  Information Request

Telecon Summary: Certificate of Compliance Form 3674
FDA Participants: Helen Gemignani
Non-FDA Participants: Valerie Mulligan
Telecon Body:

Please review your Certificate of Compliance Form 3674 and review whether it would be appropriate to check choice "C" in #9 and subsequently prudent to list the NCT number for #10.

Page Last Updated: 09/25/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English